BioInsights - Accelerating downstream analytical testing for gene therapy

Accelerating downstream analytical testing for gene therapy

Cell & Gene Therapy Insights 2022; 8(1), 23;

10.18609/cgti.2022.025

Published: 8 February 2022
Harald Ehlen

Watch the video or read the poster to learn:

  • The benefits of rapid, reliable in-process testing for AAV downstream process development
  • How utilizing Slope Spectroscopy can remove or automate multiple process steps
  • Gene therapy case studies demonstrating use of the SoloVPE System to make real-time decisions for viral vector applications

Harald Ehlen has been with Repligen for almost 2 years, supporting Biopharma analytical development, GMP implementation, and QC validation of Slope Spectroscopy® methods and instruments for rapid bioprocess analytics. Prior to working with Repligen, he gathered 6 years of experience as Senior Pharma Analytics Application Specialist and Bioproduction Application Specialist supporting Biopharma QC and Analytical Development. He graduated in Biology at the University of Cologne where he also retrieved a PhD in Physiological Chemistry and then spent several years as scientist studying the physiology, pathogenesis, and development of the skeletal system before moving to the biotech industry. When not in the lab, you can find Harald enjoying playing guitar or spending time with his wife and two children.